High-Dose Chemotherapy with Stem Cell Rescue

Treatment for Malignant neoplasm of bone and articular cartilage

Typical Dosage: Supra-myeloablative doses of various chemotherapeutics

Effectiveness
65%
Safety Score
25%
Clinical Trials
50
Participants
5K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
25
DangerousModerateSafe
Treatment Details
Dosage Range
Supra-myeloablative doses of various chemotherapeutics
Time to Effect
Weeks (engraftment and initial recovery), months for full recovery
Treatment Duration
1-3 months inpatient, prolonged outpatient recovery
Evidence Quality
MODERATE
Confidence Score
70%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$75,000
Monitoring:$75,000
Side Effect Mgmt:$50,000
Total Annual:$200,000
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
POOR
ICER
$250,000/QALY
QALYs Gained
2
Outcome-Based Costs
Cost per Responder
$500,000
Cost per Remission
$666,667
Comparison vs Conventional Salvage Chemotherapy
Cost Difference
+$100,000/year
More expensive
QALY Difference
+0.50 QALYs
Better outcomes
Dominance
No dominance
High-Dose Chemotherapy with Stem Cell Rescue Outcomes

for Malignant neoplasm of bone and articular cartilage

Efficacy Outcomes
Overall Effectiveness
+65%
Response Rate
+40%
Remission Rate
+30%
Common Side Effects
Profound Myelosuppression (infection, bleeding)
+95%
Severe Mucositis
+80%
Organ Toxicity (cardiac, renal, hepatic)
+40%
Graft-versus-host disease (allogeneic transplant)
+50%
Mortality
+7%

Sources:

nih.gov
h1.co
sci-hub.se

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

FIX IT
Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov